inspired by making <br>a difference</span>

inspired by making
a difference

Julia Schwarzenberger, a Key Account Manager in Germany, enjoys sharing information on Novocure’s treatment with health care providers and providing hope for cancer patients.

Learn More
caregiving <br>through friendship</span>

caregiving
through friendship

Laura Rowley, a glioblastoma patient who lives in Seattle, relies on her strong network of friends for support.

Learn More
GBM in the <br><span>national spotlight</span>

GBM in the
national spotlight

When high-profile people are diagnosed with this rare, yet aggressive disease, many patients feel empathy and hope for more progress.

Learn More
leaning on family<br><span> for support</span>

leaning on family
for support

Debbie Letniak, who has glioblastoma, finds strength in the support from her close-knit family.

Learn More

the story
of Novocure

In 2000, our founder Professor Yoram Palti sought to leverage his expertise in biophysics to develop a new way to treat cancer that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies. Novocure has grown into an international oncology company with more than 450 employees and operations in the U.S., Europe and Asia.

Learn More

Tumor Treating Fields, or TTFields, are low intensity, alternating electric fields.

TTFields disrupt cancer cell division through physical interactions with key molecules during mitosis. Our non-invasive treatment targets solid tumors.

OUR THERAPY

explore our clinical pipeline.

Our research shows that TTFields have an antimitotic effect in more than 15 solid tumor types in culture and in eight in vivo tumor models.

OUR PIPELINE

we are dedicated to improving the lives of cancer patients.

Patients remain at the heart of the work we do every day. Learn more about our patients, their families and the people working to deliver patient-forward therapies to treat cancer.

PATIENT-FORWARD